BillionToOne (BLLN) Return on Equity (2025 - 2026)

BillionToOne (BLLN) posted Return on Equity of 0.0% for Q1 2026, up 265.88% sequentially from 0.0% in Q4 2025.

BillionToOne (BLLN) Return on Equity (2025 - 2026) Analysis & Trends

BillionToOne (BLLN) has 2 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

  • Quarterly Return on Equity changed N/A year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed N/A YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
  • Return on Equity grew to 0.0% in Q1 2026 per BLLN's latest filing, from 0.0% in the prior quarter.
  • The five-year high for Return on Equity was 0.0% in Q3 2025, with the low at 0.0% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn 0.00%
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn 0.00%
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn 0.00%
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn 0.01%
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn 0.00%
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn 0.00%
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn 0.00%
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn 0.00%
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn -0.27%
10 BillionToOne 5.62 Bn 5.08 Bn 79.10 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%